Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-412
Closed -$833K 135
2018
Q3
$833K Sell
412
-1,249
-75% -$28.2K 0.11% 59
2018
Q2
$3.93M Buy
1,661
+1,118
+206% +$28.8K 0.61% 26
2018
Q1
$1.22M Buy
+543
New +$14.3K 0.15% 55
2017
Q4
Sell
-1,851
Closed -$5.78M 176
2017
Q3
$5.78M Sell
1,851
-48
-3% -$914 0.38% 35
2017
Q2
$3.26M Sell
1,899
-1,162
-38% -$19.8K 0.21% 53
2017
Q1
$5.36M Buy
3,061
+1,148
+60% +$17.7K 0.29% 47
2016
Q4
$2.53M Buy
1,913
+666
+53% +$9.09K 0.15% 88
2016
Q3
$1.81M Buy
1,247
+476
+62% +$5.96K 0.07% 139
2016
Q2
$760K Hold
771
0.04% 186
2016
Q1
$977K Sell
771
-99
-11% -$1.3K 0.05% 155
2015
Q4
$1.58M Buy
870
+106
+14% +$1.87K 0.09% 146
2015
Q3
$1.42M Buy
764
+365
+91% +$9.11K 0.06% 200
2015
Q2
$974K Buy
+399
New +$9.06K 0.04% 222
2014
Q2
Sell
-305
Closed -$581K 271
2014
Q1
$581K Sell
305
-1,422
-82% -$27K 0.03% 168
2013
Q4
$2.94M Buy
1,727
+287
+20% +$4.39K 0.19% 62
2013
Q3
$2.25M Buy
+1,440
New +$18.3K 0.15% 78

Other funds holding INSM

Sabby Management's INSM Position: Q4 2018 in Review

Sabby Management sold out of Insmed (INSM) in Q4 2018, closing a stake of 15,000 shares — an estimated $303K sold.

Sabby Management first reported a position in INSM in Q3 2014 and held it in 7 quarters. The position peaked at $636K in Q4 2016. 126 funds tracked by Wall St. Rank hold INSM as of Q4 2018.

  • Sabby Management reported no remaining Insmed position as of Q4 2018 after selling out during the quarter.
  • Sabby Management sold 15,000 Insmed shares in Q4 2018, an estimated $303K.
  • Sabby Management first reported a position in Insmed in Q3 2014 and held it in 7 quarters.
  • Sabby Management's Insmed position peaked at $636K in Q4 2016.
  • 126 funds tracked by Wall St. Rank held Insmed as of Q4 2018.

Based on Sabby Management's 13F filing for Q4 2018, filed 14 Feb 2019.